Startups
ACT Genomics makes personalized medicine accessible to everyone, empowering patients and doctors to stay ahead of cancer.
Overview
Location
Taiwan, Taipei
Employees
11-50
Total raised
$12.5M
Founded date
2014
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 15
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Dec 21, 2024 | The Future of Health: Bridging Science and Technology for Better Wellness | In the evolving landscape of health and wellness, two companies are making waves: Prenetics' IM8 and Ubie. Both are leveraging cutting-edge technology and partnerships to redefine how we approach health. Their recent initiatives highlight a... |
| Dec 19, 2024 | Prenetics' IM8 Announces Collaboration with Mayo Clinic to Develop New Line of Premium Supplements | Collaboration to Focus on Nutrition, Cellular Rejuvenation, Protein, Collagen and Overall Wellness IM8, a New Premium Supplements Brand, Launched Officially on November 18th on IM8health.com CHARLOTTE, N.C., Dec. 19, 2024 /PRNewswire/ -- Pr... |
| Nov 27, 2024 | Prenetics Announces Third Quarter 2024 Financial Results | Revenue Grew 59.4% to $7.8 million from Prior Year and 30.9% Sequentially Officially Launched IM8Health.com, a new premium supplements brand Tencent Invests $30 million in Insighta's Early Cancer Detection Reiterates Revenue Target to Excee... |
| Aug 19, 2024 | Prenetics Announces Acquisition of Europa Sports Partners in Strategic Expansion to Consumer Health and Wellness Industry | Europa Is One of the Largest Sports Nutrition Distributors With a Network of 10,000+ Gyms Across the United States Supports Prenetics' New Health and Wellness Brand IM8 with David Beckham as its Co-Founding Partner Projected Revenue of $100... |
| Jul 13, 2024 | Health science firm Prenetics collaborates with David Beckham for new health brand | David Beckham, a former international football player, entrepreneur, and philanthropist, has joined Prenetics, a Hong Kong-based health sciences company that is listed on the NASDAQ, as a strategic investor. A statement released by Prenetic... |
| Mar 2, 2023 | Prenetics Announces Formation of Scientific Advisory Board to Support New Business Strategy in Precision Oncology | LONDON and HONG KONG, March 2, 2023 /PRNewswire/ -- Prenetics Global Limited (NASDAQ: PRE), a leader in genomic and diagnostic testing, is proud to announce the formation of a new Prenetics Scientific Advisory Board (the 'SAB') to provide s... |
| Dec 16, 2022 | Prenetics Acquires ACT Genomics, Creating a Leader in Comprehensive Cancer Genetics and Precision Oncology | Acquisition to bring germline and somatic testing, cell-free DNA-based (liquid biopsy), and tissue-genomic profiling onto a single platform Cancer genomics testing is now standard practice for cancer care and has shown to be highly successf... |
| Dec 16, 2022 | Prenetics Acquires ACT Genomics First M&A Deal since IPO Set to Expand Footprint in Cancer Genomics | Prenetics will be acquiring a majority stake in ACT Genomics Holdings Company Limited (“ACT”) for an upfront consideration consisting of 19.9 million shares of Prenetics common stock and US$20 million cash Prenetics expects ACT to contribut... |
| Jul 29, 2021 | Sinic Holdings Company Limited Announces Partial Repurchase of USD 250 Million 9.5% Senior Notes Due 2021 and USD 250 Million 8.5% Senior Notes Due 2022 | Sinic Holdings (Group) Company Limited announced that reference is made to the announcements of the Company dated 12 October 2020, 19 October 2020, 18 January 2021, 25 January 2021 and 26 January 2021 (the "Announcements") in rela... |
Show more